Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy

Sergio A Mezzano1, Claudio A Aros, Alejandra Droguett

  • 1Division of Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile. smezzano@uach.cl

Abstract

Insights

The renin-angiotensin system (RAS) is activated in progressive idiopathic membranous nephropathy (MN), contributing to kidney injury. This study shows angiotensin II (Ang II) may drive fibrosis and disease progression in MN.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • The molecular basis of renal injury and fibrosis in proteinuric nephropathies, such as idiopathic membranous nephropathy (MN), remains incompletely understood.
  • The renin-angiotensin system (RAS) is implicated in these processes, and MN can lead to kidney failure.

Purpose of the Study:

  • To investigate the localization of RAS components in MN kidney biopsies.
  • To correlate RAS component expression with profibrotic markers and indicators of renal injury.

Main Methods:

  • Immunohistochemistry was used to assess angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) expression in 20 MN patient biopsies.
  • In situ hybridization detected transforming growth factor-beta (TGF-beta) and platelet-derived growth factor (PDGF)-BB mRNA, while alpha-smooth muscle actin (alpha-SMA) staining identified myofibroblast transdifferentiation.

Main Results:

  • Elevated ACE and Ang II levels were observed in tubular and interstitial cells, particularly in progressive MN cases.
  • TGF-beta and PDGF mRNA were upregulated in tubular epithelial cells in progressive MN and correlated with myofibroblast activation (alpha-SMA).
  • Overexpression of ACE and Ang II was associated with tubular profibrotic factor expression and interstitial myofibroblast activation.

Conclusions:

  • The intrarenal RAS is selectively activated in progressive MN.
  • De novo ACE expression suggests in situ Ang II generation contributes to TGF-beta upregulation, epithelial-myofibroblast transdifferentiation, and disease progression.
  • Angiotensin II plays a novel role in human tubulointerstitial injury in MN.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...